Consult the medical resource doctors trust

UpToDate is one of the most respected medical information resources in the world, used by over 360,000 doctors and thousands of patients to find answers to medical questions.

  • Content written by a faculty of over 4,000 physicians from leading medical institutions
  • Unbiased: free of advertising or pharmaceutical funding
  • Evidence-based treatment recommendations
  • Continuously updated to incorporate new medical findings

Causes of hypokalemia

INTRODUCTION

Hypokalemia is a common clinical problem. Potassium enters the body via oral intake or intravenous infusion, is then largely stored in the cells, and then excreted in the urine. Thus, decreased intake, increased translocation into the cells, or, most often, increased losses in the urine (or gastrointestinal tract or sweat) all can lead to potassium depletion and a reduction in the plasma potassium concentration (table 1).

This topic will review the major causes of hypokalemia. The diagnosis and treatment of hypokalemia are discussed separately. (See "Diagnosis of hypokalemia" and "Clinical manifestations and treatment of hypokalemia".)

DECREASED POTASSIUM INTAKE

The normal range of potassium intake is 40 to 120 meq per day, most of which is then excreted in the urine. The kidney is able to lower potassium excretion to a minimum of 5 to 25 meq per day in the presence of potassium depletion [1]. Thus, decreased intake alone will cause hypokalemia only in rare cases. However, it can contribute to the severity of potassium depletion when another problem is superimposed, such as diuretic therapy or the use of hypocaloric, liquid protein diets for rapid weight loss [2,3].

INCREASED ENTRY INTO CELLS

The normal distribution of potassium between the cells (which contains approximately 98 percent of exchangeable potassium) and the extracellular fluid is maintained by the Na-K-ATPase pump in the cell membrane [4]. In some cases, however, there is increased potassium entry into cells, resulting in transient hypokalemia.

An elevation in extracellular pH — Either metabolic or respiratory alkalosis can promote potassium entry into cells. In these settings, hydrogen ions leave the cells to minimize the change in extracellular pH; the necessity to maintain electroneutrality then requires the entry of some potassium (and sodium) into the cells. In general, this direct effect is relatively small, as the plasma potassium concentration falls less then 0.4 meq/L for every 0.1-unit rise in pH [5]. A similar change can be induced by the administration of sodium bicarbonate to treat metabolic acidosis; in this setting, however, a direct effect of bicarbonate may also contribute, independent of the elevation in pH [6].

To continue reading this article you need to subscribe.

Read the rest of this article and others like it

The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References Top
  1. Squires, RD, Huth, EJ. Experimental potassium depletion in normal human subjects. I. Relation of ionic intakes to the renal conservation of potassium. J Clin Invest 1959; 38:1134.
  2. Amatruda, JM, Biddle, TL, Patton, ML, Lockwood, DH. Vigorous supplementation of a hypocaloric diet prevents cardiac arrhythmias and mineral depletion. Am J Med 1983; 74:1016.
  3. Liu, T, Nagami, GT, Everett, ML, Levine, BS. Very low calorie diets and hypokalaemia: the importance of ammonium excretion. Nephrol Dial Transplant 2005; 20:642.
  4. Rose, BD, Post, TW, Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001, pp. 836-856.
  5. Adrogué, HJ, Madias, NE. Changes in plasma potassium concentration during acute acid-base disturbances. Am J Med 1981; 71:456.
  6. Fraley, DS, Adler, S. Correction of hyperkalemia by bicarbonate despite constant blood pH. Kidney Int 1977; 12:354.
  7. Clausen, T, Flatman, JA. Effect of insulin and epinephrine on Na+-K+-ATPase and glucose transport in soleus muscle. Am J Physiol 1987; 252:E492.
  8. Ferrannini, E, Taddei, S, Santoro, D, et al. Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. Am J Physiol 1988; 255:E953.
  9. Adrogué, HJ, Lederer, ED, Suki, WN, Eknoyan, G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore) 1986; 65:163.
  10. Kunin, AS, Surawicz, B, Sims, EA. Decrease in serum potassium concentrations and appearance of cardiac arrhythmias during infusion of potassium with glucose in potassium-depleted patients. N Engl J Med 1962; 266:228.
  11. Brown, MJ, Brown, DC, Murphy, MB. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med 1983; 309:1414.
  12. Morgan, DB, Young, RM. Acute transient hypokalemia: New interpretation of a common event. Lancet 1982; 2:751.
  13. Shannon, M, Lovejoy, FH Jr. Hypokalemia after theophylline intoxication. The effects of acute vs chronic poisoning. Arch Intern Med 1989; 149:2725.
  14. Lipworth, BJ, McDevitt, DG, Struthers, AD. Prior treatment with diuretic augments the hypokalemic and electrocardiographic effects of inhaled albuterol. Am J Med 1989; 86:653.
  15. Wong, CS, Pavord, ID, Williams, J, et al. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 1990; 336:1396.
  16. Goldenberg, IF, Olivari, MT, Levine, TB, Cohn, JN. Effect of dobutamine on plasma potassium in congestive heart failure secondary to idiopathic or ischemic cardiomyopathy. Am J Cardiol 1989; 63:843.
  17. Braden, GL, von Oeyen, PT, Germain, MJ, et al. Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences. Kidney Int 1997; 51:1867.
  18. Atypical reactions associated with heroin use--five states, January-April 2005. MMWR Morb Mortal Wkly Rep 2005; 54:793.
  19. Reid, JL, Whyte, KF, Struthers, AD. Epinephrine-induced hypokalemia: The role of beta adrenoceptors. Am J Cardiol 1986; 57:23F.
  20. Fontaine, B, Lapie, P, Plassart, E, et al. Periodic paralysis and voltage-gated ion channels. Kidney Int 1996; 49:9.
  21. Manoukian, MA, Foote, JA, Crapo, LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med 1999; 159:601.
  22. Ober, KP. Thyrotoxic periodic paralysis in the United States. Report of seven cases and review of the literature. Medicine (Baltimore) 1992; 71:109.
  23. Chan, A, Shinde, R, Cockram, CS, Swaminathan, R. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ 1991; 303:1096.
  24. Ko, GT, Chow, CC, Yeung, VT, et al. Thyrotoxic periodic paralysis in a Chinese population. QJM 1996; 89:463.
  25. Lin, SH. Thyrotoxic periodic paralysis. Mayo Clin Proc 2005; 80:99.
  26. Kung, AW. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab 2006; 91:2490.
  27. Soy, M, Pamuk, ON, Gerenli, M, Celik, Y. A primary Sjogren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis: Report of a case study and review of the literature. Rheumatol Int 2005; 26:86.
  28. Phakdeekitcharoen, B, Ruangraksa, C, Radinahamed, P. Hypokalaemia and paralysis in the Thai population. Nephrol Dial Transplant 2004; 19:2013.
  29. Ptacek, LJ, Tawil, R, Griggs, RC, et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 1994; 77:863.
  30. Sillen, A, Sorensen, T, Kantola, I, et al. Identification of mutations in the CACNL1A3 gene in 13 families of Scandinavian origin having hypokalemic periodic paralysis and evidence of a founder effect in Danish families. Am J Med Genet 1997; 69:102.
  31. Wang, Q, Liu, M, Xu, C, et al. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. J Mol Med 2005; 83:203.
  32. Sternberg, D, Maisonobe, T, Jurkat-Rott, K, et al. Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 2001; 124:1091.
  33. Bulman, DE, Scoggan, KA, van Oene, MD, et al. A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 1999; 53:1932.
  34. Tristani-Firouzi, M, Jensen, JL, Donaldson, MR, et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002; 110:381.
  35. Matthews, E, Labrum, R, Sweeney, MG, et al. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology 2009; 72:1544.
  36. Cannon, SC. Getting a charge out of periodic paralysis?. Neurology 2009; 72:1540.
  37. Lu, KC, Hsu, YJ, Chiu, JS, et al. Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis. Am J Emerg Med 2004; 22:544.
  38. Loh, KC, Pinheiro, L, Ng, KS. Thyrotoxic periodic paralysis complicated by near-fatal ventricular arrhythmias. Singapore Med J 2005; 46:88.
  39. Lin, SH, Lin, YF. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis 2001; 37:620.
  40. Layzer RB. Periodic paralysis and the sodium-potassium pump. Ann Neurol 1982; 11:547.
  41. Resnick, JS, Engel, WK, Griggs, RC, Stam, AC. Acetazolamide prophylaxis in hypokalemic periodic paralysis. N Engl J Med 1968; 278:582.
  42. Kim, JB, Lee, KY, Hur, JK. A Korean family of hypokalemic periodic paralysis with mutation in a voltage-gated calcium channel (R1239G). J Korean Med Sci 2005; 20:162.
  43. Bendahhou, S, Cummins, TR, Griggs, RC, et al. Sodium channel inactivation defects are associated with acetazolamide-exacerbated hypokalemic periodic paralysis. Ann Neurol 2001; 50:417.
  44. Adams, PC, Woodhouse, KW, Adela, M, Parnham, A. Exaggerated hypokalaemia in acute myeloid leukaemia. Br Med J (Clin Res Ed) 1981; 282:1034.
  45. Schaller, MD, Fischer, AP, Perret, CH. Hyperkalemia: A prognostic factor during acute severe hypothermia. JAMA 1990; 264:1842.
  46. Clemessy, JL, Favier, C, Borron, SW, et al. Hypokalaemia related to acute chloroquine ingestion. Lancet 1995; 346:877.
  47. Malik, AR, Wolf, PK, Ravasia, S. Hypokalemia from risperidone and quetiapine overdose. Can J Psychiatry 2005; 50:76.
  48. Older, J, Older, P, Colker, J, Brown, R. Secretory villous adenomas that cause depletion syndromes. Arch Intern Med 1999; 159:879.
  49. Agarwal, R, Afzalpurkar, R, Fordtran, JS. Pathophysiology of potassium absorption and secretion by the human intestine. Gastroenterology 1994; 107:548.
  50. Sitprija, V. Altered fluid, electrolyte and mineral status in tropical disease, with an emphasis on malaria and leptospirosis. Nat Clin Pract Nephrol 2008; 4:91.
  51. Rose, BD, Post, TW, Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001, pp. 333-344.
  52. Curran, MP, Plosker, GL. Oral sodium phosphate solution: A review of its use as a colorectal cleanser. Drugs 2004; 64:1697.
  53. Bennett, A, Stryjewski, G. Severe hypokalemia caused by oral and rectal administration of bentonite in a pediatric patient. Pediatr Emerg Care 2006; 22:500.
  54. Ukaonu, C, Hill, CA, Christensoen, F. Hypokalemic myopathy in pregnancy caused by clay ingestion. Obstet Gynecol 2003; 102:1169.
  55. Young, DB. Quantitative analysis of aldosterone's role in potassium regulation. Am J Physiol 1988; 255:F811.
  56. Mohr, JA, Clark, RM, Waack, TC, Whang, R. Nafcillin-associated hypokalemia. JAMA 1979; 242:544.
  57. Carlisle, EJ, Donnelly, SM, Vasuvattakul, S, et al. Glue-sniffing and distal renal tubular acidosis: Sticking to the facts. J Am Soc Nephrol 1991; 1:1019.
  58. Carlisle, EJ, Donnelly, SM, Ethier, JH, et al. Modulation of the secretion of potassium by accompanying anions in humans. Kidney Int 1991; 39:1206.
  59. Lambert, AP, Close, C. Life-threatening hypokalaemia from abuse of Nurofen Plus. J R Soc Med 2005; 98:21.
  60. Whang, R, Whang, DD, Ryan, MP. Refractory potassium depletion. A consequence of magnesium deficiency. Arch Intern Med 1992; 152:40.
  61. Douglas, JB, Healy, JK. Nephrotoxic effects of amphotericin B, including renal tubular acidosis. Am J Med 1969; 46:154.
  62. Peters, M, Jeck, N, Reinalter, S, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 2002; 112:183.
  63. Aldinger, KA, Samaan, NA. Hypokalemia with hypercalcemia: Prevalence and significance in treatment. Ann Intern Med 1977; 87:571.
  64. Mir, MA, Brabin, B, Tang, OT, et al. Hypokalaemia in acute myeloid leukaemia. Ann Intern Med 1975; 82:54.
  65. Perazella, MA, Eisen, RN, Frederick, WG, Brown, E. Renal failure and severe hypokalemia associated with acute myelomonocytic leukemia. Am J Kidney Dis 1993; 22:462.
  66. Wrong, OM, Feest, TG, MacIver, AG. Immune-related potassium-losing interstitial nephritis: A comparison with distal renal tubular acidosis. Q J Med 1993; 86:513.
  67. Hariprasad, MK, Eisinger, RP, Nadler, IM, et al. Hyponatremia in psychogenic polydipsia. Arch Intern Med 1980; 140:1639.
  68. Knochel, JP, Dotin, LN, Hamburger, RJ. Pathophysiology of intense physical conditioning in a hot climate. I. Mechanisms of potassium depletion. J Clin Invest 1972; 51:242.
  69. Godek, SF, Godek, JJ, Bartolozzi, AR. Hydration status in college football players during consecutive days of twice-a-day preseason practices. Am J Sports Med 2005; 33:843.
  70. Dave, S, Honney, S, Raymond, J, Flume, PA. An unusual presentation of cystic fibrosis in an adult. Am J Kidney Dis 2005; 45:e41.
  71. Kosunen, KJ, Pakarinen, AJ. Plasma renin, angiotensin II, and plasma and urinary aldosterone in running exercise. J Appl Physiol 1976; 41:26.
  72. Rostand, SG. Profound hypokalemia in continuous ambulatory peritoneal dialysis. Arch Intern Med 1983; 143:377.
  73. Wiegand, CF, Davin, TD, Raij, L, Kjellstrand, CM. Severe hypokalemia induced by hemodialysis. Arch Intern Med 1981; 141:167.
  74. Orlin, JB, Berkman, EM. Partial plasma exchange using albumin replacement: Removal and recovery of normal plasma constituents. Blood 1980; 56:1055.
white circle LOG IN
white circle DEMO